 |
Articles: Drug/Product Approvals |
Prior Articles
Multaq Recommended for Approval in the European Union
Sanofi-aventis, 09/28/09
Free full text
Novartis bronchodilator QAB149 recommended for approval in European Union to treat patients with chronic obstructive pulmonary disease
Novartis, 09/28/09
Free full text
Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration
Annals of Pharmacotherapy, 09/25/09 Anti-Cancer Agent Xeloda and Avastin Obtained Approval for Additional Indication of Colorectal Cancer
Chugai Pharmaceutical Co., 09/25/09
Free full text
Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
Cephalon, 09/25/09
Free full text
European Commission Grants Conditional Marketing Authorization to Cayston for the Treatment of Chronic Pulmonary Infections Due to Pseudomonas Aeruginosa in Patients with Cystic Fibrosis
Gilead, 09/24/09
Free full text
Physio-Control Receives Market Approval from Health Canada for LIFEPAK 15 Monitor/Defibrillator
Medtronic, 09/23/09
Free full text
MedImmune Receives U.S. Government Order for Additional 29 Million Doses of Nasal Spray Vaccine for 2009 H1N1 Influenza
Medimmune, 09/22/09
Free full text
King Announces Commercial Availability of Embeda™
King Pharmaceuticals, 09/22/09
Free full text
Abbott Receives FDA Approval for First Fully Automated Blood Screening Test for HIV-1/HIV-2
Abbott, 09/22/09 Antineoplastic Agent / Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Tarceva Application for Approval of Additional Indication of Pancreatic Cancer
Chugai Pharmaceutical Co., 09/22/09
Free full text
Four H1N1 influenza vaccines licensed by FDA
American Pharmacists Association, 09/21/09
Free full text
Report Shows Buffalo Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases
PhRMA, 09/21/09
Free full text
Update on FDA Registration of Actemra, a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody for Rheumatoid Arthritis
Chugai Pharmaceutical Co., 09/21/09
Free full text
Antineoplastic Agent / Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Tarceva®Application for Approval of Additional Indication of Pancreatic Cancer
Chugai Pharmaceutical Co., 09/21/09
Free full text
Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next-Generation Everolimus Stent
Boston Scientific, 09/21/09
Free full text
APP Pharmaceuticals Receives Approval for Deferoxamine Mesylate for Injection, USP
American Pharmaceutical Partners, 09/18/09
Free full text
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09
Free full text
FDA actions in brief, September 2009 (Saphris, Tracleer, Livalo, Tyvaso, Tekturna HCT, Onsolis, Forteo, Invega Sustenna, Colcrys, Acuvail, Lipsovir, Kogenate FS)
Formulary, 09/17/09
Free full text
Bevacizumab: Monoclonal antibody approved for the treatment of metastatic renal cell carcinoma in combination with interferon alfa
Formulary, 09/17/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
